Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Viatris Healthcare Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland
Efexor XL 150 mg prolonged-release capsules, hard.
| Pharmaceutical Form |
|---|
|
Prolonged-release capsule, hard. Opaque dark orange capsules printed in white with ‘W’ and ‘150’, hard gelatin capsule, size 0 (23.5 mm x 7.65 mm). |
Efexor XL 150 mg: Each prolonged-release capsule contains 169.7 mg of venlafaxine hydrochloride, equivalent to 150 mg of venlafaxine free base.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Venlafaxine |
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. |
| List of Excipients |
|---|
|
Capsule contents: Microcrystalline cellulose Capsule shell: Gelatin Capsule printing ink: Shellac, |
Clear or opaque PVC/Aluminium foil blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100.
Hospital packs of 500 (10x50), 1000 (10x100).
PVC/Aluminium foil blister unit dose packs of 14, 28, 84, 100.
High-density polyethylene (HDPE) bottles of 14, 20, 50, 100; Hospital packs of 500, 1000.
Not all pack sizes may be marketed.
Viatris Healthcare Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland
PA23355/002/003
Date of first authorisation: 26th July 1999
Date of last renewal: 20th October 2014
| Drug | Countries | |
|---|---|---|
| EFEXOR | Australia, Brazil, Cyprus, Ecuador, Estonia, Finland, Hong Kong, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
